Total assets · 2011–2025
Travere Therapeutics total assets
$605M+1.9% · FY2025
Travere Therapeutics (TVTX) reported $605M in total assets for fiscal 2025, +1.9% year on year.
| Fiscal year | Total assets | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $605M | +1.9% | Open → |
| FY20242024-12-31 | $594M | −24.7% | Open → |
| FY20232023-12-31 | $789M | +17.3% | Open → |
| FY20222022-12-31 | $673M | −13.4% | Open → |
| FY20212021-12-31 | $777M | +27.9% | Open → |
| FY20202020-12-31 | $607M | +0.4% | Open → |
| FY20192019-12-31 | $605M | −14.7% | Open → |
| FY20182018-12-31 | $709M | +36.3% | Open → |
| FY20172017-12-31 | $520M | −0.9% | Open → |
| FY20162016-12-31 | $525M | +2.5% | Open → |
| FY20152015-12-31 | $512M | +278.1% | Open → |
| FY20142014-12-31 | $135M | +560.9% | Open → |
| FY20132013-12-31 | $20.5M | +757.2% | Open → |
| FY20122012-12-31 | $2.4M | +12,119.0% | Open → |
| FY20112011-12-31 | $19,570 | — | Open → |
Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +109.3%
Total assets at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Travere Therapeutics total assets |url=https://companiesranked.com/en/company/travere-therapeutics/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Travere Therapeutics total assets. CompaniesRanked. https://companiesranked.com/en/company/travere-therapeutics/total-assetsBibTeX
@misc{companiesranked-en-company-travere-therapeutics-total-assets-2026,
author = {{CompaniesRanked}},
title = {{Travere Therapeutics total assets}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/travere-therapeutics/total-assets}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001438533-26-000063 · August 4, 2026
{{cite web |title=Travere Therapeutics total assets — 10-Q (0001438533-26-000063) |url=https://www.sec.gov/Archives/edgar/data/1438533/000143853326000063/tvtx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.